10-K annual report · filed Feb 23, 2026

PROASSURANCE CORP (PRA) FY2025 10-K Annual Report

Short answer

PROASSURANCE CORP (PRA) filed its fiscal 2025 10-K annual report with the SEC on Feb 23, 2026. It reported revenue of $1.1B (−4.6% year over year) and net income of $51M.

  • Top risk flagged: Regulatory risk: expiration of Terrorism Risk Insurance Act (TRIA) at end of 2027 could increase terrorism loss exposure and raise premium costs

FY2025 key financial metrics · XBRL

Revenue
$1.1B
−4.6% YoY
Net income
$51M
−3.5% YoY
EPS (diluted)
$0.99
−3.9% YoY
ROE
3.8%
−0.6 pp YoY
Operating cash flow
−$26M
−139.1% YoY

Source: XBRL data from the PROASSURANCE CORP (PRA) FY2025 10-K on SEC EDGAR. USD.

PROASSURANCE CORP FY2025 10-K analysis

AI summary of each section, grounded in the filing text

Business Overview

  • Core business: Specialty property and casualty (P&C) insurance, with focus on medical professional liability (MPL) and workers' compensation segments
  • New 100% quota share reinsurance agreement in Q2 2025 for legal professional liability policies, impacting ceded premiums ratio
  • Strategic emphasis on improving profitability via proactive premium volume management, ceasing Syndicate 1729 participation for 2024
  • Notable quantitative: Net favorable reserve development $79.8 million in 2025, up 116% from $36.9 million in 2024
  • Unusual: Incorporation of podiatric and chiropractic policies into MPL treaty effective October 1, 2024, expanding risk coverage

Management Discussion & Analysis

  • Revenue details not explicitly disclosed in MD&A provided; gross premiums by product: Specialty P&C 71%, Workers' Compensation 23% of consolidated gross premiums written in 2025
  • No explicit profit/margin % figures given; focus on combined ratio, underwriting profitability and ROE targeting 700 bps above 10-year US Treasury of 11.2% (approx. 18.2% target ROE)
  • Best performing segment: Specialty P&C (largest, 71% of premiums, 86% of reserve gross losses); Worst pressure in Workers’ Compensation with rate pressure and loss cost declines
  • Forward outlook: Merger with The Doctors Company expected by June 30, 2026 with regulatory approvals pending; risks include healthcare market consolidation, social inflation, tort reform erosion, and regulatory timing uncertainties

Risk Factors

  • Regulatory risk: expiration of Terrorism Risk Insurance Act (TRIA) at end of 2027 could increase terrorism loss exposure and raise premium costs
  • Geopolitical risk: ongoing exposure to aviation losses linked to Russia’s invasion of Ukraine in open Lloyd’s Syndicate 6131 2021 underwriting year
  • Operational risk: reliance on independent agents and brokers whose loss or consolidation could adversely impact new business acquisition and retention
  • Competitive risk: intensified competition in medical professional liability market from mutual insurers with lower ROE and aggressive multistate entities
  • Financial risk: $335 million reinsurance receivable on unpaid losses subject to reinsurer credit and payment timing uncertainties potentially affecting liquidity

Generated from the filing text; verify against the original. How to read a 10-K

Ask about this 10-K

Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.